1 / 2

UK Genomic Biomarker Market

The UK genomic biomarker market is estimated to grow significantly at a CAGR of more than 15% during the forecast period. The major factors driving market growth include a high prevalence of cancer and chronic diseases in the region. The healthcare expenditure in UK has increased significantly as compared to that of other countries in the European region. This is one of the prime reasons which is expected to increase the investment in R&D of new technologies such as genomic biomarkers for the treatment of chronic diseases. Further, the prevalence of cardiac diseases has been increasing in UK.

nabeelomr
Download Presentation

UK Genomic Biomarker Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The UK genomic biomarker market is estimated to grow significantly at a CAGR of more than 15% during the forecast period. The major factors driving market growth include a high prevalence of cancer and chronic diseases in the region. The healthcare expenditure in UK has increased significantly as compared to that of other countries in the European region. This is one of the prime reasons which is expected to increase the investment in R&D of new technologies such as genomic biomarkers for the treatment of chronic diseases. Further, the prevalence of cardiac diseases has been increasing in UK. (Get 15% Discount on Buying this Report) Get Report Sample Copy @ https://www.omrglobal.com/request-sample/uk-genomic- biomarkers-market UK has the highest number of CVD, CHD, Stroke, heart failure, atrial fibrillation, and other heart patients. The use of genomic biomarker is used to implement the suitable drug therapy to the patients suffering from cardiovascular diseases, thereby providing personalized treatment options to the patient and thereby creating opportunities for the growth of the market in the near future. A Full Report of Global IoT Sensors Market is Available at: https://www.omrglobal.com/industry-reports/uk-genomic-biomarkers-market Market Segmentation UK Genomic Biomarker Market by Application Oncology Cardiology Neurology Others UK Genomic Biomarker Market by End-User Hospitals Diagnostic & Research Laboratories

  2. Company Profiles Avacta Group Plc Bayer AG BioMérieux S.A. Bio-Rad Laboratories, Inc. DestiNA Genomics Ltd. Eagle Genomics Ltd. Epistem Ltd Eurofins Scientific SE Reasons to Buying From us – 1. We cover more than 15 major industries, further segmented into more than 90 sectors. 2. More than 120 countries are for analysis. 3. Over 100+ paid data sources mined for investigation. 4. Our expert research analysts answer all your questions before and after purchasing your report. For https://www.omrglobal.com/report-customization/uk-genomic-biomarkers-market More Customized Data, Request for Report Customization @ About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: anurag@omrglobal.com Contact no: +91 780-304-0404

More Related